North America Mycoplasma Testing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments and Services), By Technology, By Application, By End User, By Country and Growth Forecast, 2023 - 2030

The North America Mycoplasma Testing Market would witness market growth of 10.8% CAGR during the forecast period (2023-2030).

Mycoplasma testing refers to detecting and identifying mycoplasma bacteria in biological samples, such as cell cultures and clinical samples. Mycoplasma is a group of small bacteria that lack a cell wall and survive in various environments, including laboratory cell cultures. They can contaminate cell cultures, leading to changes in the behaviour and characteristics of the cells and affecting the experimental research results. Therefore, this testing is important in cell culture research and manufacturing biological products to ensure the purity of the cultures and prevent contamination.

Mycoplasma contamination in the complex processes of biopharmaceutical production can result in substantial financial losses, production delays, and compromised product quality. The imperative drives the adoption of this testing in this sector to identify and mitigate the risk of contamination early in the production chain. Robust testing protocols are integral to ensuring the integrity of biopharmaceutical products and safeguarding investments in research and development.

Biomanufacturing facilities in Mexico, producing vaccines, monoclonal antibodies, and other biopharmaceuticals, implement this testing as a critical quality control measure. The development and manufacturing of cell-based therapies in Mexico, including regenerative medicine and personalized cell therapies, drive the need for this testing. Facilities involved in cell line banking in Mexico, where cells are stored and distributed for research and production purposes, implement this testing to maintain the quality of stored cell lines. This testing plays a role in preventive healthcare measures in Mexico, particularly in diagnostic laboratories where cell cultures are used for various diagnostic purposes. Advances in cell and gene therapies in Mexico contribute to the growing importance of this testing. Therefore, the factors mentioned above will drive the regional market growth.

The US market dominated the North America Mycoplasma Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $541.8 million by 2030. The Canada market is experiencing a CAGR of 13.3% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 12.3% during (2023 - 2030).

Free Valuable Insights: The Mycoplasma Testing Market is Predict to reach $1.9 Billion by 2030, at a CAGR of 11.5%

Based on Product & Service, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into PCR, ELISA, Microbial Culture Techniques, and Enzymatic Methods. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End of Production Cells Testing, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Cell Banks, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific, Inc.
• Eurofins Scientific SE
• Lonza Group Ltd.
• Bio-Rad Laboratories, Inc.
• InvivoGen SAS
• Asahi Kasei Corporation
• F.Hoffmann-La Roche Ltd.
• Norgen Biotek Corp.
• PromoCell GmbH

North America Mycoplasma Testing Market Report Segmentation

By Product & Service

• Kits & Reagents
• Instruments
• Services

By Technology

• PCR
• ELISA
• Microbial Culture Techniques
• Enzymatic Methods

By Application

• Cell Line Testing
• Virus Testing
• End of Production Cells Testing
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Cell Banks
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Mycoplasma Testing Market, by Product & Service
1.4.2 North America Mycoplasma Testing Market, by Technology
1.4.3 North America Mycoplasma Testing Market, by Application
1.4.4 North America Mycoplasma Testing Market, by End User
1.4.5 North America Mycoplasma Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Mycoplasma Testing Market by Product & Service
4.1 North America Kits & Reagents Market by Country
4.2 North America Instruments Market by Country
4.3 North America Services Market by Country

Chapter 5. North America Mycoplasma Testing Market by Technology
5.1 North America PCR Market by Country
5.2 North America ELISA Market by Country
5.3 North America Microbial Culture Techniques Market by Country
5.4 North America Enzymatic Methods Market by Country

Chapter 6. North America Mycoplasma Testing Market by Application
6.1 North America Cell Line Testing Market by Country
6.2 North America Virus Testing Market by Country
6.3 North America End of Production Cells Testing Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Mycoplasma Testing Market by End User
7.1 North America Pharmaceutical & Biotechnology Companies Market by Country
7.2 North America Contract Research Organizations Market by Country
7.3 North America Academic Research Institutes Market by Country
7.4 North America Cell Banks Market by Country
7.5 North America Others Market by Country

Chapter 8. North America Mycoplasma Testing Market by Country
8.1 US Mycoplasma Testing Market
8.1.1 US Mycoplasma Testing Market by Product & Service
8.1.2 US Mycoplasma Testing Market by Technology
8.1.3 US Mycoplasma Testing Market by Application
8.1.4 US Mycoplasma Testing Market by End User
8.2 Canada Mycoplasma Testing Market
8.2.1 Canada Mycoplasma Testing Market by Product & Service
8.2.2 Canada Mycoplasma Testing Market by Technology
8.2.3 Canada Mycoplasma Testing Market by Application
8.2.4 Canada Mycoplasma Testing Market by End User
8.3 Mexico Mycoplasma Testing Market
8.3.1 Mexico Mycoplasma Testing Market by Product & Service
8.3.2 Mexico Mycoplasma Testing Market by Technology
8.3.3 Mexico Mycoplasma Testing Market by Application
8.3.4 Mexico Mycoplasma Testing Market by End User
8.4 Rest of North America Mycoplasma Testing Market
8.4.1 Rest of North America Mycoplasma Testing Market by Product & Service
8.4.2 Rest of North America Mycoplasma Testing Market by Technology
8.4.3 Rest of North America Mycoplasma Testing Market by Application
8.4.4 Rest of North America Mycoplasma Testing Market by End User

Chapter 9. Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 Eurofins Scientific SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Recent strategies and developments:
9.3.4.1 Product Launches and Product Expansions:
9.3.4.2 Acquisition and Mergers:
9.3.5 SWOT Analysis
9.4 Lonza Group Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 InvivoGen SAS
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Asahi Kasei Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Norgen Biotek Corp.
9.9.1 Company Overview
9.10. PromoCell GmbH
9.10.1 Company Overview
9.10.2 SWOT Analysis

TABLE 1 North America Mycoplasma Testing Market, 2019 - 2022, USD Million
TABLE 2 North America Mycoplasma Testing Market, 2023 - 2030, USD Million
TABLE 3 North America Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
TABLE 4 North America Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
TABLE 5 North America Kits & Reagents Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Kits & Reagents Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Instruments Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Instruments Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Services Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Services Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
TABLE 12 North America Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
TABLE 13 North America PCR Market by Country, 2019 - 2022, USD Million
TABLE 14 North America PCR Market by Country, 2023 - 2030, USD Million
TABLE 15 North America ELISA Market by Country, 2019 - 2022, USD Million
TABLE 16 North America ELISA Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Microbial Culture Techniques Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Microbial Culture Techniques Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Enzymatic Methods Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Enzymatic Methods Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
TABLE 22 North America Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
TABLE 23 North America Cell Line Testing Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Cell Line Testing Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Virus Testing Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Virus Testing Market by Country, 2023 - 2030, USD Million
TABLE 27 North America End of Production Cells Testing Market by Country, 2019 - 2022, USD Million
TABLE 28 North America End of Production Cells Testing Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
TABLE 32 North America Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
TABLE 33 North America Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
TABLE 34 North America Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
TABLE 35 North America Contract Research Organizations Market by Country, 2019 - 2022, USD Million
TABLE 36 North America Contract Research Organizations Market by Country, 2023 - 2030, USD Million
TABLE 37 North America Academic Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 38 North America Academic Research Institutes Market by Country, 2023 - 2030, USD Million
TABLE 39 North America Cell Banks Market by Country, 2019 - 2022, USD Million
TABLE 40 North America Cell Banks Market by Country, 2023 - 2030, USD Million
TABLE 41 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 42 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 43 North America Mycoplasma Testing Market by Country, 2019 - 2022, USD Million
TABLE 44 North America Mycoplasma Testing Market by Country, 2023 - 2030, USD Million
TABLE 45 US Mycoplasma Testing Market, 2019 - 2022, USD Million
TABLE 46 US Mycoplasma Testing Market, 2023 - 2030, USD Million
TABLE 47 US Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
TABLE 48 US Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
TABLE 49 US Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
TABLE 50 US Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
TABLE 51 US Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
TABLE 52 US Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
TABLE 53 US Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
TABLE 54 US Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
TABLE 55 Canada Mycoplasma Testing Market, 2019 - 2022, USD Million
TABLE 56 Canada Mycoplasma Testing Market, 2023 - 2030, USD Million
TABLE 57 Canada Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
TABLE 58 Canada Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
TABLE 59 Canada Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
TABLE 60 Canada Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
TABLE 61 Canada Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
TABLE 62 Canada Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
TABLE 63 Canada Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
TABLE 64 Canada Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
TABLE 65 Mexico Mycoplasma Testing Market, 2019 - 2022, USD Million
TABLE 66 Mexico Mycoplasma Testing Market, 2023 - 2030, USD Million
TABLE 67 Mexico Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
TABLE 68 Mexico Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
TABLE 69 Mexico Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
TABLE 70 Mexico Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
TABLE 71 Mexico Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
TABLE 72 Mexico Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
TABLE 73 Mexico Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
TABLE 74 Mexico Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
TABLE 75 Rest of North America Mycoplasma Testing Market, 2019 - 2022, USD Million
TABLE 76 Rest of North America Mycoplasma Testing Market, 2023 - 2030, USD Million
TABLE 77 Rest of North America Mycoplasma Testing Market by Product & Service, 2019 - 2022, USD Million
TABLE 78 Rest of North America Mycoplasma Testing Market by Product & Service, 2023 - 2030, USD Million
TABLE 79 Rest of North America Mycoplasma Testing Market by Technology, 2019 - 2022, USD Million
TABLE 80 Rest of North America Mycoplasma Testing Market by Technology, 2023 - 2030, USD Million
TABLE 81 Rest of North America Mycoplasma Testing Market by Application, 2019 - 2022, USD Million
TABLE 82 Rest of North America Mycoplasma Testing Market by Application, 2023 - 2030, USD Million
TABLE 83 Rest of North America Mycoplasma Testing Market by End User, 2019 - 2022, USD Million
TABLE 84 Rest of North America Mycoplasma Testing Market by End User, 2023 - 2030, USD Million
TABLE 85 Key Information – Charles River Laboratories International, Inc.
TABLE 86 Key Information – Thermo Fisher Scientific, Inc.
TABLE 87 Key Information – Eurofins Scientific SE
TABLE 88 Key Information –Lonza Group Ltd.
TABLE 89 Key Information – Bio-Rad Laboratories, Inc.
TABLE 90 Key Information – InvivoGen SAS
TABLE 91 Key Information – Asahi Kasei Corporation
TABLE 92 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 93 Key Information – Norgen Biotek Corp.
TABLE 94 Key Information – PromoCell GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Mycoplasma Testing Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Mycoplasma Testing Market
FIG 4 Porter’s Five Forces Analysis – Mycoplasma Testing Market
FIG 5 North America Mycoplasma Testing Market share by Product & Service, 2022
FIG 6 North America Mycoplasma Testing Market share by Product & Service, 2030
FIG 7 North America Mycoplasma Testing Market by Product & Service, 2019 - 2030, USD Million
FIG 8 North America Mycoplasma Testing Market share by Technology, 2022
FIG 9 North America Mycoplasma Testing Market share by Technology, 2030
FIG 10 North America Mycoplasma Testing Market by Technology, 2019 - 2030, USD Million
FIG 11 North America Mycoplasma Testing Market share by Application, 2022
FIG 12 North America Mycoplasma Testing Market share by Application, 2030
FIG 13 North America Mycoplasma Testing Market by Application, 2019 - 2030, USD Million
FIG 14 North America Mycoplasma Testing Market share by End User, 2022
FIG 15 North America Mycoplasma Testing Market share by End User, 2030
FIG 16 North America Mycoplasma Testing Market by End User, 2019 - 2030, USD Million
FIG 17 North America Mycoplasma Testing Market share by Country, 2022
FIG 18 North America Mycoplasma Testing Market share by Country, 2030
FIG 19 North America Mycoplasma Testing Market by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 21 SWOT Analysis: Eurofins Scientific SE
FIG 22 SWOT Analysis: Lonza Group Ltd.
FIG 23 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 24 SWOT Analysis: InvivoGen SAS
FIG 25 SWOT Analysis: Asahi Kasei Corporation
FIG 26 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 27 SWOT Analysis: PromoCell GmbH